Predictors of extrahepatic recurrence after transarterial chemoembolization as first-line therapy for hepatocellular carcinoma

被引：0
|
作者：
Pinto, Elisa [1 ]
Pelizzaro, Filippo [1 ]
Vitale, Alessandro [1 ]
Giannini, Edoardo [2 ]
Trevisani, Franco [3 ]
Farinati, Fabio [1 ]
机构：
[1] Univ Padua, Padua, Italy
[2] Univ Genoa, Genoa, Italy
[3] Univ Bologna, Bologna, Italy
来源：
JOURNAL OF HEPATOLOGY | 2023年 / 78卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
FRI-308
引用
收藏
页码：S511 / S512
页数：2
相关论文
共 50 条
  • [41] A rare complication after transarterial chemoembolization for hepatocellular carcinoma
    Huang, Y. -S.
    Chang, C. -C.
    Chang, Y. -C.
    QJM-AN INTERNATIONAL JOURNAL OF MEDICINE, 2014, 107 (06) : 487 - 488
  • [42] Comparison of treatment efficacy and safety between drug-eluting bead transarterial chemoembolization with CalliSpheres® microspheres and conventional transarterial chemoembolization as first-line treatment in hepatocellular carcinoma patients
    Ma, Yilong
    Zhao, Chang
    Zhao, Hui
    Li, Haiping
    Chen, Changyong
    Xiang, Hua
    Zheng, Chuansheng
    Ma, Cong
    Luo, Chao
    Qiu, Huaiming
    Yao, Yuanhui
    Hu, Hongyao
    Xiong, Bin
    Zhou, Jun
    Zhu, Hui
    Long, Qingyun
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2019, 11 (12): : 7456 - 7470
  • [43] Re-evaluation of lipiodolized transarterial chemoembolization therapy for intrahepatic recurrence of hepatocellular carcinoma after curative liver resection
    Eguchi, Susumu
    Matsumoto, Shigehiro
    Hamasaki, Koji
    Takatsuki, Mitsuhisa
    Hidaka, Masaaki
    Tajima, Yoshitsugu
    Sakamoto, Ichiro
    Kanematsu, Takashi
    JOURNAL OF HEPATO-BILIARY-PANCREATIC SURGERY, 2008, 15 (06): : 627 - 633
  • [44] Lenvatinib combined with transarterial chemoembolization as first-line treatment of advanced hepatocellular carcinoma: A phase 3, multicenter, randomized controlled trial
    Peng, Zhenwei
    Fan, Wenzhe
    Zhu, Bowen
    Li, Jiaping
    Kuang, Ming
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (04)
  • [45] Lenvatinib Combined With Transarterial Chemoembolization as First-Line Treatment for Advanced Hepatocellular Carcinoma: A Phase III, Randomized Clinical Trial (LAUNCH)
    Peng, Zhenwei
    Fan, Wenzhe
    Zhu, Bowen
    Wang, Guoying
    Sun, Junhui
    Xiao, Chengjiang
    Huang, Fuxi
    Tang, Rong
    Cheng, Yu
    Huang, Zhen
    Liang, Yuchuang
    Fan, Huishuang
    Qiao, Liangliang
    Li, Fuliang
    Zhuang, Wenquan
    Peng, Baogang
    Wang, Jiping
    Li, Jiaping
    Kuang, Ming
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (01) : 117 - +
  • [46] Erratum to: Risk factors for recurrence after transarterial chemoembolization for early-stage hepatocellular carcinoma
    Hideaki Kinugasa
    Kazuhiro Nouso
    Yasuto Takeuchi
    Tetsuya Yasunaka
    Hideki Onishi
    Shin-ichiro Nakamura
    Hidenori Shiraha
    Kenji Kuwaki
    Hiroaki Hagihara
    Fusao Ikeda
    Yasuhiro Miyake
    Akinobu Takaki
    Kazuhide Yamamoto
    Journal of Gastroenterology, 2012, 47 (4) : 489 - 489
  • [47] Serum interleukin-8 as an indicator of tumor recurrence in hepatocellular carcinoma after transarterial chemoembolization
    Zhong, Maofeng
    Zhai, Xiaofeng
    Lin, Wanfu
    Liu, Qun
    Yao, Man
    Guo, Yuyu
    Cheng, Binbin
    Ling, Changquan
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2020, 13 (05): : 3540 - 3547
  • [48] The prognostic factors of recurrence in hepatocellular carcinoma after transarterial chemoembolization (TACE) induced complete response
    Jeong, Soung Won
    Choo, Jin Woo
    Jang, Jae Young
    Kim, Jin Nyoung
    Kwon, Soon Ha
    Lim, Dae Seop
    Park, Eui Ju
    Lee, Sae Hwan
    Kim, Sang Gyune
    Cha, Sang-Woo
    Kim, Young Seok
    Cho, Young Deok
    Kim, Hong Soo
    Kim, Boo Sung
    Choi, Dong Ho
    Kim, Young Jae
    HEPATOLOGY, 2012, 56 : 472A - 473A
  • [49] Predictors of poor outcome for transarterial chemoembolization (TACE) in hepatocellular carcinoma (HCC).
    Prins, Petra
    Singh, Bhavana P.
    Armstrong, Samantha Ann
    He, Aiwu Ruth
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [50] COMBINATION THERAPY WITH TRANSARTERIAL CHEMOEMBOLIZATION AND RADIOFREQENCY ABLATION COMPARED WITH TRANSARTERIAL CHEMOEMBOLIZATION OR RFA FOR EARLY HEPATOCELLULAR CARCINOMA
    Kwon, J. H.
    Song, M. J.
    Song, D. S.
    Kim, H. Y.
    Yoo, S. H.
    Park, C. -H.
    Bae, S. H.
    Choi, J. Y.
    Yoon, S. K.
    Lee, Y. S.
    Lee, C. D.
    JOURNAL OF HEPATOLOGY, 2012, 56 : S404 - S404
12345